Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Intra-Cellular Therapies, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 4 | 1 | −3 |
| Shares | 52.8K | 1 | −52.8K (−100.0%) |
| Value | $4.15M | $2.54K | −$4.15M (−99.9%) |
New holders (0)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
None.
Sold out (3)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| DekaBank Deutsche Girozentrale | 51,997 | $4.09M |
| Advisor Group Holdings, Inc. | 797 | $60.1K |
| Kestra Investment Management, LLC | 44 | $5.80K |